CDC panel delays vote on newborn hepatitis B vaccine
Digest more
Vaccine advisers to the US Centers for Disease Control and Prevention may vote this week to make a major change to the childhood vaccine schedule, potentially delaying a dose of the hepatitis B vaccine given to newborns by weeks or even years.
The CDC’s Advisory Committee on Immunization Practices (ACIP) began its December 4 and 5, 2025, meeting today, launching two full days of presentations, public comment and planned votes that could reshape how infants and children receive hepatitis B (HepB) vaccines and other routine immunizations.
Public health experts warn any delay to the newborn dose of the hepatitis B vaccine could threaten decades of progress.
Comments by President Trump, Health Secretary Robert F. Kennedy Jr. and some panelists suggest the committee is likely to delay hepatitis B shots and discuss revising the use of other vaccines.